Abaxx Technologies will launch Gold Singapore CNH Cash-Settled futures on November 16, 2026, offering a new way to trade Singapore kilobar gold priced in offshore Chinese renminbi (CNH). This contract supports regional hedging and cross-market strategies between Singapore and Hong Kong bullion markets, facilitating better price management for physical gold inventory. The launch complements Abaxx's LNG North Pacific Asia CNH futures, expanding CNH-denominated trading options and connecting physical commodity markets with offshore renminbi trading. This move aims to strengthen Asia's role in global commodity markets as China’s commodity markets become more integrated internationally.
Abaxx's upcoming launch of CNH-denominated Singapore Gold Futures provides context for market activity on Pluang. For readers following market breadth, as of Nov 11, 2026 18:11 WIB, out of 150 priced US stocks tradable on Pluang, 88 rose and 60 fell. Notable movers include HPE at USD 50.88 with a 6.08% gain and 94% buy order activity, AMAT at USD 395.15 up 6.07% with 64% sell orders, and TSM at USD 418.13 rising 5.46% with 63% buy orders and a typical hold time of 114 days.
NRx Pharmaceuticals has begun selling a new preservative-free ketamine made in the U.S., addressing a shortage that has persisted since 2018. This ketamine uses innovative blow-fill-seal technology, eliminating the preservative benzethonium chloride,...
FLSmidth & Co. A/S announced its financial calendar for 2027, including key dates for the annual report, interim financial reports, and the annual general meeting. The company emphasizes its commitment to sustainability with its MissionZero goal to a...
Dimensional Fund Advisors Ltd. has filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc, totaling 12,054,886 shares as of November 10, 2026. This disclosure is part of regulatory requirements under the Takeover Code, indicatin...
Dimensional Fund Advisors Ltd. has filed a disclosure showing it holds a 1.61% stake in DCC Energy plc's ordinary shares as of November 10, 2026. The firm sold 42,998 shares recently at a price of £64.5585 each. This disclosure is part of regulatory ...
Novo Nordisk has committed $200 million to the World Diabetes Foundation for 2027–2036 to enhance diabetes prevention and care in low- and middle-income countries. This funding aims to improve equitable access to diabetes services in underserved comm...
